You are here: Industry Insights > MND

News List

Sheffield University gets £1.6 mn grant from Medical Research Council expresspharma
January 27, 2021
Researchers from the University of Sheffield’s Institute for Translational Neuroscience (SITraN) have been awarded a £1.6 million grant from the Medical Research Council (MRC).
Experimental motor neurone disease therapy shows promise europeanpharmaceuticalreview
July 15, 2020
Tofersen reduced expression of the SOD1 gene known to cause amyotrophic lateral sclerosis (ALS) and slowed clinical decline in the Phase I/II trial.
Experimental motor neurone disease therapy shows early promise pharmatimes
July 14, 2020
An experimental therapy developed to address the genetic cause of a Amyotrophic lateral sclerosis (ALS), rare form of motor neurone disease (MND) has shown encouraging results in early research supported by the NIHR.
ALS global day emphasises need for a cure despite promising late-stage pipeline pharmaceutical-technology
June 23, 2020
The International Alliance of Amyotrophic Lateral Sclerosis (ALS)/Motor Neuron Disease (MND) Associations recognises 21 June as the ALS Global Day.
Statins could protect against motor neurone disease, scientists suggest pharmaphorum
February 18, 2019
High cholesterol could be a risk factor in development of motor neurone disease, according to a study of genetic data by UK scientists.
ALS Organizations Collaborate to Advance New Therapeutic into Trials pharmafocusasia
December 03, 2018
Several ALS organizations announced on Wednesday that the first participant was successfully given a dose of AT-1501 in the first in-human trial of the potential treatment for ALS.
Zebrafish help unlock mystery of motor neurone disease expressbpd
November 29, 2018
Trialing 1,000 drugs on mice models would take more than 10 years, however trialling 1,000 drugs on zebrafish would take only a couple of months
Ebselen provides promising new avenue for treatment of MND europeanpharmaceuticalreview
May 23, 2018
An international study has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease…
Researchers initiate new non-invasive urinary test to fast-track drugs for Motor Neuron Disease pharmaceutical-technology
February 28, 2017
Researchers at Flinders University in South Australia (SA) and the University of Miami, US, have initiated a new non-invasive urinary test that can pick up signals of Motor Neuron Disease (MND) in patients.